Panel Discussion: A new era in the management of irritable bowel syndrome with constipation (IBS-C)
Résumé
In Canada, there is significant Irritable bowel syndrome (IBS) burden which negatively impacts health care utilization, economic productivity, and most importantly patients’ quality of life and psychosocial wellbeing. In this panel discussion, experts in the diagnosis and treatment of IBS discuss new strategies for diagnosing IBS-C, clinical trial data for novel therapies in IBS-C and appropriate choices of therapies according to individual patient characteristics. Methods for achieving treatment success and patient satisfaction are also discussed.
Références
Téléchargements
Publié
Comment citer
Numéro
Rubrique
Licence
© Canadian Primary Care Today 2023

Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.